Abstract
Maf1, a general transcriptional regulator and mTOR downstream effector, is highly expressed in the hippocampus and cortex, but the function of Maf1 in neurons is not well elucidated. Here, we first demonstrate that Maf1 plays a central role in the inhibition of dendritic morphogenesis and the growth of dendritic spines both in vitro and in vivo. Furthermore, Maf1 downregulation paradoxically leads to activation of AKT-mTOR signaling, which is mediated by decreased PTEN expression. Moreover, we confirmed that Maf1 could regulate the activity of PTEN promoter by luciferase reporter assay, and proved that Maf1 could bind to the promoter of PTEN by ChIP-PCR experiment. We also demonstrate that expression of Maf1 in the hippocampus affects learning and memory in mice. Taken together, we show for the first time that Maf1 inhibits dendritic morphogenesis and the growth of dendritic spines through AKT-mTOR signaling by increasing PTEN expression.
Similar content being viewed by others
Introduction
Dendrites receive synaptic inputs from other neurons through the somato-dendritic compartment via protrusions called spines, dendritic arborization, and spine formation and are, therefore, critical for the function of neurons1,2. The proper formation and morphogenesis of dendrites require specific precise control by external cues and intrinsic genetic programs2. Transcriptional control of gene expression represents the main mode of cell internal regulation of dendrite growth controlled by transcription factors, and thus, transcription factors have emerged as key players in dendrite growth3. In recent years, a number of transcription factors have been discovered to play important roles in promoting dendritic growth at different stages of dendrite morphogenesis3. Nonetheless, the transcription factors that negatively regulate dendritic development remain largely unknown.
Maf1, a transcriptional repressor of RNA polymerase (pol)III, was initially identified in yeast4,5, has been found to be highly expressed in the brain and enriched in the hippocampus and the cortex6. In addition, Maf1 was found to be a mammalian target of rapamycin (mTOR) downstream effector7, while the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway has been implicated in neurite outgrowth8, neuronal growth9, survival10, synaptic plasticity11, and dendritic arbor development12,13. In this report, we demonstrate that Maf1 negatively regulates dendritic outgrowth through PI3K-AKT-mTOR signaling in cultured hippocampal neurons. Moreover, we found that Maf1 affects the learning and memory ability of mice by negatively regulating the growth of dendritic spines in vivo.
Materials and methods
Animal care and maintenance
ICR mice (National Rodent Laboratory Animal Resources Shanghai Branch, China) were used in this study. All procedures involving animal experiments conducted in this study were approved and monitored by the Animal Care Committee of the Shanghai Jiao Tong University School of Medicine. No manipulations were performed until animals were given 1 week to acclimate. Animals were housed in cages under a 12-h light/dark cycle prior to the experiment, with free access to food pellets and water.
DNA constructs
The Maf1 gene was amplified from hippocampal cDNA by PCR. Then, the Maf1 gene was digested with the Xbal1/Not1 enzyme and constructed with the pGFP-C-ShLenti vector. The plasmids were packaged into lentiviruses. The viruses were generated by cotransfection of two helper plasmids (pVSVG and pCMV189) into the packaging cell line HEK293T at a ratio of 5:6:6 pGFP-C-ShLenti-Maf1: pVSVG: pCMV189. Viruses were harvested 48 h after transfection by collecting the medium from transfected cells and were stored at −80 °C.
Viral construct generation and stereotaxic injection
The Maf1 ShRNA sequences were as follows: ShRNA1: TTGGAGAACTCCAGCTTTGAGGCCATCAA; ShRNA2: TCTGCTTAGCTGAGTGTGACATCTACAGC; and scramble ShRNA (ShSCR): GCACTACCAGAGCTAACTCAGATAGTACT. All ShRNAs were constructed in the pGFP-C-ShLenti vector, and the lentivirus was packaged as mentioned above. To confirm the specificity of the observed Maf1 knockdown phenotype in neurons, ShRNA2 and ShSCR were constructed in the pMT vector. The sequence of PTEN ShRNA (AGGTGAAGATATATTCCTCCAA) was designed against mouse PTEN as described previously14 constructed in the pLVX-IRES-mCherry vector, and the lentivirus was packaged as mentioned above.
ShRNA1 and Maf1 for mice were also constructed with the pAAV-CMV-td-Tomato-ShRNA vector or the pAAV-CMV-td-Tomato-3Flag vector, respectively. Packages of AAV9-ShRNA viruses were provided by Shanghai Sunbio Medical Biotechnology, Shanghai, China.
For stereotaxic injection, P1 pups were gently anesthetized with ice for 5–10 min and placed on a stereotactic frame. For bilateral hippocampal area injection, P1 pups were randomly subjected to inject 1 µl AAV9-flag-Maf1 or AAV9- ShRNA -Maf1 into the hippocampus (1 mm posterior and 1 mm left to the midline and 1.2 mm deep into the skull surface). Following injection, the needle was kept at the injection point for an additional 10 min. After injection, the pups were collected on a 37 °C warm plate for recovery. After regaining mobility, the injected pups were rolled in home cage bedding and returned to their mother as a group. Six weeks after viral injection, the infected mice were killed and processed for immunostaining, electron microscopy, WB, or the Morris water maze (MWM).
Cell cultures, transfection, and drug treatment
Primary hippocampal cultures were prepared from embryonic day 18 (E18) mouse brains15. Dissociated neurons were seeded onto poly-d-lysine and cultured in neurobasal medium containing a B27 supplement and GlutaMAX at a density of 75,000/well. At 7 days in vitro (DIV), hippocampal neurons were transfected with the indicated plasmids using the calcium phosphate method16 for 6–14 days. When possible, cells were stained for the appropriate epitope tags and GFP to confirm cotransfection. However, in the specific phase of verifying that Maf1 regulates dendritic growth of neurons, three plasmids were cotransfected, and pMT-GFP was mixed with two other plasmids at a ratio of 1:2:2. Rapamycin (Cell Signaling Technology) was added 8 h after transfection to a final concentration of 100 nM. For lentivirus-infected neurons, the cells were transduced at the indicated DIV by adding concentrated lentivirus at a multiplicity of infection (m.o.i.) of 0.5 to the growing media.
Western blotting
For Western blotting (WB), the procedures were performed as previously described17. Briefly, cells were homogenized and solubilized at 4 °C for 30 min in lysis buffer (1% CHAPS, 2.7 mM KCl, 137 mM NaCl, 1.4 mM KH2PO4, 4.3 mM Na2HPO4, pH 7.2, 5 mM EGTA, 5 mM EDTA, 1 mM PMSF, 1 mM Na3VO4, 50 mM NaF, and protease inhibitors). Then, lysates were clarified via centrifugation at 4 °C to remove the insoluble deposit, run on 10% polyacrylamide gels, and then transferred to nitrocellulose membranes. Membranes were blocked for 1–2 h in TBST (150 mM NaCl, 10 mM Tris, 0.1% Tween 20, and pH 7.6) containing 10% BSA. The primary antibodies were diluted in blocking buffer and incubated with membrane overnight at 4 °C. After washing with TBST three times, the blots were incubated with HRP-conjugated secondary antibodies for 1 h at room temperature. After washing with TBST three times again, the blots were exposed to enhanced chemiluminescence substrate. Quantification was performed by analyzing the relative density of the exposed film using Image J.
To dissect the CA1 region for western blot, after killing the mice, they were transcardially perfused with 0.9% saline (4 °C) until the blood was flushed out, afterward the brains were quickly removed and immersed in saline, then the hippocampus was taken from the brain and carefully dissect the CA1 region with microdissection equipment under a dissection microscope at 4 °C.
As primary antibodies for WB, we used mouse anti-β-actin (1:5000, Thermo Fisher Scientific, MA5-15739), mouse anti-GAPDH (1:5000, Sigma-Aldrich, G8795), mouse anti-Flag (1:1000, Sigma, A3682), rabbit anti-Maf1 (1:1000, Abcam), anti-p-Akt (1:1000, Cell Signaling Technology, 4060 s), anti-Akt (1:1000, Cell Signaling Technology, 2920 s), p-mTOR (1:1000, Cell Signaling Technology, 5536 s), anti-mTOR (1:1000, Cell Signaling Technology, 2972 s), anti-PTEN (1:1000, Cell Signaling Technology, 9188 s), anti-p-P70S6K(1:1000, Cell Signaling Technology, 9208 s), anti-P70S6K (1:1000, Cell Signaling Technology, 9202 s), anti-p-S6 (1:1000, Cell Signaling Technology, 5364 s), and anti-S6 (1:1000, Cell Signaling Technology, 2217 s).
Quantitative real-time PCR
Total RNA was extracted from primary hippocampal cultures using TRIZOL (Invitrogen, USA) following the manufacturer’s instructions. cDNA was treated with the cDNA synthesis kit (Thermo Fisher Scientific) according to the standard protocol. RT-qPCR was performed on the MX3000P System (Stratagene) using Brilliant SYBR Green QPCR Master Mix (Stratagene). The primer sequences are: PTEN, forward primer, 5′-TGGGGAAGTAAGGACCAGAG-3′, reverse primer, 5′-GGCAGACCACAAACTGAGGA-3′. β-actin, forward 5′-CATCCGTAAAGACCTCTATGCCAAC-3′, and reverse, 5′-ATGGAGCCACCGATCCACA-3′. Relative amounts of product transcripts were quantified with the comparative threshold cycle method (DDCt), β-actin was used as an endogenous reference control.
Luciferase assay
The overexpression cell line of Maf1 was constructed by infecting HT22 cells with lentivirus, and then the recombinant plasmid pGFP-C-PTEN was cotransfected with the control plasmid pMT vector, 48 h after transfection, cells were collected and lysed for luciferase assays using a dual luciferase assay kit (Promega, USA) according to the manufacturer’s instructions.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) assay was performed based on the EZ ChIP™ Chromatin Immunoprecipitation Kit (Millipore, USA) according to the manufacturer’s protocol. Independent chip-PCR assay was used to confirm that identified maf1 regulated PTEN, and DNA fragments of immunoprecipitate were pulled down by anti Maf1 antibody (Abcam) or IgG control antibody (Santa Cruz Biotechnology). The enriched DNA was analyzed by real-time PCR. PTEN primer sequences are: forward primer, 5′-ATTCCGCTGCCTCGGCTGCCAG-3′, reverse primer, 5′-GATGGAAATGGCTCTGGACTTG-3′. Primers for pre-tRNALeu are forward, 5′-GACCCAGTGGCCTAATGGATA-3′, and reverse, 5′-TGGCGACCCAGATGGGACTC-3′. Primers for GAPDH are forward, 5′-AGGAGAGTGTTTGTAAGTCTC-3′, and reverse, 5′-GAGGCCTGGCTTGTGTACCGC-3′.
Immunofluorescence staining
Primary mouse hippocampal neurons were fixed in PBS containing 4% PFA and 4% sucrose for 30 min at 4 °C. For the brain slice immunofluorescence assay, after cardiac perfusion of mice with 4% PFA and fixation with 4% PFA at 4 °C overnight, 30 μm coronal brain slices were generated. After washing with PBS, both the cells and brain slices were incubated for blocking with permeable buffer (0.3% Triton X-100 in PBS) containing 10% donkey serum for 45–60 min at room temperature. The cells were then incubated with the primary antibodies (diluted in blocking buffer) at 4 °C for 24 h. Dual-immunofluorescence experiments were performed using the following primary antibodies: rabbit anti-Maf1 (1:1000 for cell, 1:100 for slice, Abcam), chicken anti-Map2 (1:10,000 for cell, 1:1000 for slice, Aves Labs, MAP), goat anti-Vglut2 ((1:10,000 for cell, 1:1000 for slice, Abcam, 101760), mouse anti-Flag (1:10,000, Sigma, A3682), and cell nuclei stained with DAPI. The sections or cells were washed three times (10 min for each wash) in 1× PBS plus 0.1% Triton X-100 and then incubated with Alexa Fluor secondary antibodies conjugated to Alexa488 and Alexa555 specific for the primary antibody host plus DAPI for 1 h at room temperature. Following incubation with secondary antibodies, sections were washed three times (10 min each) in PBS, and the chamber slides were then mounted with mounting medium and imaged.
Image analysis and quantification
Confocal images (Leica SP8) were used to analyze single- and double-transfected neurons. Objectives of 20, 40, and 63× were used. Morphometric analysis and quantification were performed as described previously16. Briefly, a z-series of 7–12 images with a 0.5 m–1 μm depth interval, each averaged two times, was taken at 1024 × 1024 pixel resolutions. The resultant stack was flattened into a single image using a maximum intensity projection. For fluorescence intensity analysis, the confocal settings were constant for all of the scans. MetaMorph image analysis software (Universal Imaging Corporation, Downingtown, PA) was used to analyze and quantify the whole-cell morphometry. A ×20 objective was used to measure the total dendrite length (TDL). All dendrites of individual neurons were traced, and the number of pixels was automatically counted and converted to micrometers with MetaMorph. For the dendrite tip number, we calculated the tip of all non-axon protrusions over 10 μm. For Sholl analysis, we drew concentric circles of 15 μm in diameter around the cell body and manually counted the number of dendrites passing through each circle. To calculate the size of the cell somatic cells, the cell soma was outlined, and the pixel area in squared micrometers was automatically calculated. For the analysis of dendritic spines, neurons were imaged with Leica SP8 microscope with a ×63 objective and 2 zoom with 1024 × 1024 pixel resolution. To quantify the shape of the spine and to classify the shape of neuronal spines, the procedure described by Zhu XN et al.17 was employed. GFP-positive cells, td-Tomato-positive cells, or dual-labeled neurons were assessed.
Transmission electron microscopy (TEM)
Mice were anesthetized and perfused with 2% PFA/2% glutaraldehyde in 0.1 M phosphate buffer. Brains were dissected, embedded in chicken albumin agar, and cut into 500 μm sections using a motorized vibrating-blade microtome. CA1 hippocampal regions were dissected, cut into 1 mm2 pieces, and further post-fixed with 3% EM grade glutaraldehyde. Ultrathin tissue sections were stained with conventional osmium-uranium-lead method containing 1% ethanolic phosphotungstic acid. The CA1 hippocampus was visualized using a Philips CM-10 TEM operating at 80 kV. Sections were placed on a grid, and nonoverlapping randomized photographs (N20/section) were taken throughout the entirety of the CA1 stratum radiatum. Photographs were digitized, and an investigator blinded to the experimental groups quantified synapses manually. The inclusion criteria for excitatory synapses included the presence of pre- and postsynaptic membranes with a discernible synaptic cleft, the presence of asymmetric pre- and postsynaptic densities, and the presence of synaptic vesicles at the presynaptic terminal as described previously. Pre- and postsynaptic densities from quantified synapses were measured for synaptic area and length using ImageJ.
Morris water maze
Morris water maze test (MWM) was conducted according to our previous study18. Briefly, sixth weeks after AAV-9 injection, learning and memory functions were evaluated. The maze consists of a circular black pool with a diameter of 120 cm and a depth of 50 cm. A black platform with a diameter of 6 cm and a height of 30 cm was placed in the northeast quadrant of the pool. The pool was filled with 22 ± 1 °C water, and the platform was hidden 1 cm below the water surface. In each experiment, mice were released from one of four directions (east, south, west, and north) and allowed to swim. Each mouse was allowed to discover the underwater platform for 60 s. When the mouse found the platform, it was allowed to rest for 20 s on the platform. If the mouse failed to find the platform within 60 s, it was guided to the platform and allowed to remain there for 20 s. The mice were placed in a dry cage followed each trial. Each mouse was tested across four trials starting from four different start positions each day for 5 consecutive days. On the 6th day, each mouse was tested in one trial to assess memory function. Mouse movement was recorded using a video tracking system (DigBehv, Jiliang Software Technology Company, Shanghai, China), and the results were collected and calculated for statistical analysis. A total of 48 mice, 12 per group contributed to the MWM test.
Statistical analysis
Data are represented as mean ± standard error (SEM) from at least three biologic replicates for experiments. Statistical differences were determined by Student’s t test for two-group comparisons or ANOVA followed by Dunnett’s test for multiple comparisons among more than two groups.
Results
Knockdown of endogenous Maf1 in hippocampal neurons promotes the branching of dendrites and the growth of dendritic spines
Firstly, immunoblotting was used to detect the expression of Maf1 in 12-week-old mice tissues, Maf1 was found expressed in almost all tissues, especially in the brain, spinal cord, eyes, thymus, lung, liver, and spleen (Supplementary Fig. 1a). In brain, Maf1 was found highly expressed in the hippocampus, cortex, corpus callosum, cerebellum, brainstem, and thalamus (Supplementary Fig. 1b), which was also confirmed by immunofluorescence assay (Supplementary Fig. 1c, d). Maf1 was also found coexisted with the neuron dendritic marker Map2 in brain slices and cultured neurons, which indicates that Maf1 is expressed in neuron dendrites (Supplementary Fig. 1e).
To investigate the function of endogenous Maf1 in dendrite growth, we targeted Maf1 with two different ShRNAs: ShMaf1-1 and ShMaf1-2. All the ShRNAs have a high knockdown efficiency above 60% knockdown at the protein level (Fig. 1a). ShRNAs directed against Maf1 effectively decreased the level of endogenous protein compared with the un-transfected neurons or in ShSCR-transfected (Fig. 1b). After establishing the effectiveness of ShRNAs tools, we tested the effects of decreased Maf1 activity on dendritic arbor development. Sholl analysis was used to quantify the branching pattern of dendritic trees. In neurons transfected with ShMaf1-1 or ShMaf1-2, the number of crossings reached a peak at 60–65 μm from the cell body, and the number of crossings at 140 μm was still much higher than that in control neurons (Fig. 1c, d). Knockdown of endogenous Maf1 in neurons also leads to a strong increase in cell soma (Fig. 1c, e). In addition, TDL significantly increased under these conditions (by 26% and 29% for ShMaf1-1-GFP, ShMaf1-2-GFP, respectively; Fig. 1f). Finally, transfection with ShMaf1-1 or ShMaf1-2 increased the total number of dendritic tips (TNDT; 38% and 36%, respectively, Fig. 1c, g). Taken together, these results indicate that knocking down Maf1 in neurons promotes the growth of neuron dendrites.
In addition to the significant changes in overall dendritic morphology, knockdown of endogenous Maf1 in neurons also displayed prominent alterations in dendritic spine morphology. 14 days after transfection, knockdown Maf1 increased spine density (by 46% and 41% for ShMaf1-1, ShMaf1-2, respectively; Fig. 1h, i). We also found knockdown Maf1 increased the density of mushroom-shaped spines while reduced the density of filopodia/thin-like protrusions (Fig. 1h, j). There was an increase in mushroom spines by 12.6 and 11.0%, respectively, with a reduction in thin/filopodia-like spines by 12.4 and 14.2%.
Overexpression of Maf1 in hippocampal neurons suppresses dendrite branching and the growth of dendritic spines in vitro
As knockdown of endogenous Maf1 in hippocampal neurons promotes the branching of dendrites and the growth of dendritic spines, we speculate that Maf1 plays a negative regulatory role in the process of neuron dendritic growth. To test this hypothesis, we overexpressed Maf1 in cultured hippocampal neurons. The overexpression of Maf1 was confirmed by WB and immunofluorescence (Fig. 2a, b). As shown in Fig. 2b, staining for Maf1 was significantly increased compared with the un-transfected cells or in Vector-transfected control. In addition, staining for Flag was only shown in Maf1-OE transfected cells.
In contrast to the effect of knocking down Maf1 in neurons, overexpression of Maf1 in neurons suppresses dendrite branching (Fig. 2c). Sholl analysis showed the “peak” of branching in Maf1-OE shifted to the left (Fig. 2d). Maf1 also inhibited cell growth effects, as measured by quantification of the cell body area (Fig. 2e). In addition, the Maf1-OE neurons showed an ~28% decrease in TDL and an ~29% decrease in TNDT (Fig. 2c, f, g). Taken together, these results indicate that Maf1 in neurons can suppress the growth of neuron dendrites.
Maf1 overexpression also suppressed the growth of dendritic spines. In all, 14 days after transfection with Maf1-OE, neurons showed an ~20% decrease in the density of spines (Fig. 2h, i), which also decreased the density of mushroom-shaped spines but increased the density of filopodia/thin-like protrusions. There was a significant decrease in mushroom spines by 10.2%, with an increase in thin/filopodia-like spines by 7.7% (Fig. 2h, j).
The dendritic growth effects promoted by silencing Maf1 are rescued by overexpression of Rat Maf1
To further confirm the specificity of the observed Maf1 knockdown phenotype in neurons, we performed “rescue” experiments with plasmids encoding rat Maf1 cDNAs that should not be recognized by ShRNAs designed against mouse sequences. First, we transiently expressed Rat-Maf1 (myc-tagged) in HEK293 cells (Fig. 3a). We then cotransfected ShRNAs and Rat-Maf1 in HEK293 cells, only ShMaf1-2 did not silence the expression of myc-tagged R-Maf1, consistent with the high homology of ShMaf1-1-targeted sequences between mouse and rat (Fig. 3b). Therefore, in the “rescue” experimental phase, the ShMaf1-2 plasmid was used, referred to as ShMaf1.
Hippocampal neurons were simultaneously transfected with ShMaf1 and either a plasmid that encoded R-Maf1 (myc-tagged) or a suitable ShRNA vector. Neurons transfected with ShMaf1 and Vector served as an additional control. In all variants, plasmids that encoded GFP were added to the transfection to visualize the morphology of transfected neurons. The simultaneous knockdown of endogenous Maf1 and overexpression of R-Maf1 significantly prevented the phenotypic effects of Maf1 knockdown (Fig. 3c). Sholl analysis revealed that at most measured distances, especially those closer to the cell soma, the number of crossings was significantly decreased in “rescue” variants (ShMaf1+R-Maf1) compared with knockdown variants (ShMaf1+Vector); the “peak” of branching was shifted leftward in the ShMaf1+R-Maf1-transfected cells compared with knockdown variants (Fig. 3d). In ShMaf1-trasfected cells, R-Maf1 overexpression significantly decreased cell body area (Fig. 3e). Nevertheless, the cell body area did not reach the values of ShSCR/R-Maf1-transfected cells (Fig. 3e). With Maf1 knockdown, the effect of introducing ShMaf1 on TDL (29% increase) was fully restored by the simultaneous overexpression of R-Maf1 (Fig. 3c, f). Similarly, the level of TNDT was highly rescued (Fig. 3f).
In addition, we found that silencing Maf1 promoted dendritic spine growth effects and could also be rescued by overexpression of Rat Maf1 (Fig. 3h–j). In all, 14 days after transfection on DIV7, ShSCR/R-Maf1 showed a significant increase in the number of filopodia/thin-like protrusions with a concomitant significant reduction in the density of mushroom-shaped spine, which was consistent with the effect of overexpression Maf1, while ShMaf1/Vector-transfected neurons showed a significant increase in the density of mushroom-shaped spines. However, the simultaneous knockdown of Maf1 and overexpression of R-Maf1 significantly prevented the phenotypic effects of Maf1 knockdown. For ShMaf1-trasfected neurons, R-Maf1 overexpression significantly decreased the density of spines (from 33% for ShMaf1/Vector to −13% for ShMaf1/R-Maf1 compared with ShSCR/Vector, Fig. 3i). We also found that neurons transfected with ShSCR/R-Maf1 showed a significant increase in the density of filopodia/thin-like protrusions with a concomitant significant reduction in the density of mushroom-shaped spines compared with knockdown variants (Fig. 3j).
Maf1 negatively regulates AKT-mTOR signaling in the dendritic growth of hippocampal neurons
As Maf1 is a major effector of PI3K-Akt signaling, we speculated that Maf1 may regulate dendritic growth by regulating the PI3K/AKT signaling pathway. Indeed, Maf1 knockdown increased phosphorylation of AKT, mTOR, P70S6K, and S6 in neurons, indicating the activation of AKT-mTOR signaling (Fig. 4a). Conversely, Maf1 overexpression reduced AKT-mTOR signaling (Fig. 4b). Maf1 knockdown also reduced PTEN protein (Fig. 4c) and mRNA (Fig. 4e) in neurons, while Maf1 overexpression increased PTEN protein (Fig. 4d) and mRNA (Fig. 4f). These results indicate that Maf1 may be downregulated at posttranscriptional level of PTEN in neurons. In order to clarify how Maf1 regulates the expression of PTEN, we performed the luciferase reporter assay in HT22 cells. As the result showed that overexpression of Maf1 resulted in a significant increase in the activity of the full-length PTEN promoter (−1551 to −1 base pair [bp]; Fig. 4g). Further analysis showed that the Maf1 reaction region is located between −1551 and −980 bp of the PTEN promoter, rather than between −839 and 0 bp (Fig. 4g). ChIP assays confirmed that Maf1 were recruited to the promoter regions of PTEN and tRNALEU, but not the promoter of glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Fig. 4h), which demonstrates the specificity of the ChIP assay. Taken together, these results indicate that Maf1 acted as a transcription activator to enhance PTEN promoter activity and further negatively regulate PI3K/AKT/mTOR signaling.
Knockdown of Maf1 promoting dendritic growth can be rescued by rapamycin
To test whether Maf1 regulates dendritic complexity through mTOR, we used a specific inhibitor of mTOR, rapamycin. Neurons were infected by lenti-ShSCR or lenti-ShMaf1 at 6 DIV and treated with 100 nM rapamycin over the following 7 days. This treatment was enough to prevent the phenotypic effects of the Maf1 knockdown, which decreased the phosphorylation of AKT/mTOR signaling (Fig. 5a, b). In ShSCR-transfected cells, rapamycin decreased the number of crossings at all measured points beyond 30 μm (Fig. 5c, d). Rapamycin also decreased TDL in ShSCR-transfected cells by ~28% and TNDT by ~32% compared with control cells transfected with ShSCR/DMSO (Fig. 5c, e, f). Furthermore, rapamycin shifted the Sholl plots of neurons with knockdown of Maf1 back to the control size and shape (Fig. 5c, d), and rapamycin abolished the increase in TDL and TNDT induced by knockdown of Maf1 in neurons (Fig. 5e, f). Taken together, rapamycin simplified dendritic arbor morphology and abolished the phenotypic effects of Maf1 knockdown in neurons.
Overexpression of Maf1 suppressing dendritic growth can be partially rescued by knockdown PTEN
To determine whether altered PTEN expression plays a role in Maf1 suppression of dendrite branching, we used short hairpin RNA (ShRNA) to knockdown PTEN in Maf1-overexpressing neurons. PTEN knockdown blunts the ability of Maf1 overexpression to suppress phosphorylation of AKT, mTOR, P70S6K, and S6 (Fig. 6a, b). Then we transfected DIV6 neurons with Vector or Maf1-OE and treated them with lenti-ShRNA-PTEN-mCherry or control vector lenti-mCherry 2 days later, some of the neurons transfected with GFP-enriched plasmids were colocalized with the lentivirus-infected neurons with mCherry were found (Fig. 6c). PTEN knockdown in neurons increased the number of crossings at all measured points beyond 20 μm, and the number of crossings at 140 μm was still much higher than that in the Vector/mCherry neurons (Fig. 6d, e). PTEN knockdown also increased the TDL in Vector by ~33% and the TNDT by ~32% compared with control with Vector/mCherry (Fig. 6d, f, g). On the other hand, PTEN knockdown partially inactivated the ability of MAF1-OE to inhibit dendritic branching. Sholl analysis showed that compared with Maf1-OE/lenti-Vector-mCherry, the number of crossings at the maximum was significantly different, and the “peak” of branching was shifted rightward in Maf1-OE/lenti-ShRNA-PTEN-mCherry (Fig. 6d, e). In Maf1-OE transfected neurons, PTEN knockdown increased TDL by ~31% and TNDT by ~31% (Fig. 6d, f, g). These observations indicate that Maf1 positively regulates PTEN expression, which is important for Maf1 to regulate dendritic growth of hippocampal neurons.
Maf1 negatively regulates the growth of dendritic spines in vivo
To further investigate the function of Maf1 on neuron dendrites in vivo, we utilized rAAV-td-Tomato-mediated delivery. At postnatal day 1, rAAV was injected into the CA1 area with stereotactic microinjections. A total of 12 mice, 3 mice per group contributed for stereotaxic injection. Six weeks later, the CA1 hippocampus area was infected with the AAV virus, as indicated by red fluorescence (Supplementary Fig. 2a). The expression of Maf1 following AAV-td-Tomato injection was then confirmed by WB, the Maf1 protein expression was significantly increased in rAAV-Maf1-OE compared with rAAV-Vector-td-Tomato (Supplementary Fig. 2b, c), while the expression of Maf1 was suppressed in rAAV-ShMaf1 but not with rAAV-ShSCR.
Six weeks after rAAV-td-Tomato injection, rAAV-Maf1-OE showed a significant decrease in spine density by 26% compared with rAAV-Vector, while rAAV-ShMaf1 showed a ~16% increase in the density of spines compared with rAAV-ShSCR (Fig. 7a, b). Consistent with in vitro studies, we also found that overexpression of Maf1 reduced the density of mushroom-shaped spines and increased the density of filopodia/thin-like protrusions, while knockdown of Maf1 by rAAV increased the density of mushroom-shaped spines and decreased the density of filopodia/thin-like protrusions in vivo (Fig. 7c).
To evaluate whether the changed spines are associated with synapses, we examined the synaptic ultrastructure in the CA1 of the hippocampus at 6 weeks following rAAV injection (Fig. 7d–g). In all, 10 regions of interest from four nonadjacent sections in each CA1 stratum radiatum from the hippocampus were imaged to quantify synaptic structures. Asymmetric synapses were quantified if there was a presynaptic terminal containing synaptic vesicles, a submembrane postsynaptic density (PSD), and a visually discrete synaptic cleft. Mice overexpressing Maf1 showed a significant ~18.5% reduction (p < 0.001) in synaptic number compared with vector controls, while Maf1 knockdown in the CA1 stratum radiatum resulted in a significant increase (p < 0.001) in synaptic number compared with ShSCR scramble controls, suggesting that Maf1 may regulate synaptic formation or maintenance during development (Fig. 7e). However, there was no change in the length and thickness of PSDs with overexpression or knockdown of Maf1 in the hippocampus.
Expression of Maf1 in the hippocampus affects learning and memory in mice
To determine the effect of Maf1 expression in the hippocampus on learning and memory behaviors, we subjected mice to a behavioral assay, namely, the fixed platform version of the MWM. At postnatal day 1, we carried out bilateral hippocampal injections of rAAV. 6 weeks later, the mice were subjected to MWM learning acquisition trials for 5 consecutive days. A probe trial that measured the ability of mice to locate the quadrant that previously contained the hidden platform was carried out 24 h after the final acquisition trial on day 6.
All the groups of mice showed daily improvements in the ability to locate the hidden platform during the acquisition trials of the MWM task; however, acquisition deficits were observed in Maf1-OE mice. The average latency to find the hidden platform increased significantly from day 3 in rAAV-Maf1-OE mice relative to Vector control mice. In contrast, knockdown of Maf1 (rAAV-ShMaf1) resulted in reduced latency from day 4 compared with scramble rAAV-ShSCR control (Fig. 8a). During probe trial testing, the different percentages of time spent in quadrants were first analyzed to evaluate the preference of mice for the target quadrant compared with the other three quadrants. We found that mice of the rAAV-Vector, rAAV-ShSCR or rAAV-ShMaf1 groups spent a significantly higher percentage of time in the target quadrant, which had contained the platform during training (p < 0.05) than in the other three quadrants (Fig. 8b). However, the rAAV-Maf1-OE mice showed spatial memory impairment, as indicated by the lack of significant differences for preference between the target quadrant and the other quadrants (p > 0.1; Fig. 8b). Subsequent analysis was performed to evaluate the distribution of time that the mice spent in the target quadrant (NE) of all groups. We found a significant difference between the rAAV-Vector group and the rAAV-Maf1-OE group (p < 0.05). However, compared with rAAV-ShSCR mice, although the distribution of time that rAAV-ShMaf1 mice spent in the quadrants showed a certain increase, there was no significant difference (p > 0.05). This result indicates that the capacity to learn the task and memory performance of rAAV-ShMaf1 mice were the same as those of rAAV-ShSCR mice. In addition, we found no evidence that exercise performance was impaired, as swimming speed was unaffected on any day of acquisition testing or the probe trial (Fig. 8c, d). Taken together, these findings demonstrate that Maf1 inhibits dendritic morphogenesis and the growth of dendritic spines through AKT-mTOR signaling by increasing PTEN expression (Fig. 8e).
Discussion
The development of dendrites and spines in mammals is a complex process2. Accumulating evidence highlights the importance of transcription factors in the control of dendrite morphogenesis2,3,19. There has been great interest in studying the role of transcription factors as negative regulators of dendritic growth. For instance, MeCP2 is a ubiquitous protein that acts as a global repressor of transcription and was found to be involved in Rett syndrome (RTT)20,21, either elimination or overexpression MeCP2 leads to a decrease in the complexity of dendritic arbors22; MeCP2 also strongly inhibits dendritic and spine growth, which depends on the interaction of MeCP2 and DiGeorge syndrome critical region 8 (DGCR8)23. Moreover, increased global transcriptional repressor element 1 (RE-1) silencing transcription factor (REST/NRSF) activity was found in several neurological diseases, such as Huntington’s disease and cerebral ischemia24. Overexpression of REST in primary hippocampal neurons significantly reduced dendritic length and arborization, while knockdown of REST had no difference in dendritic development25. In addition, the brain-enriched protein FOXO6 suppressed the growth of dendrites while simultaneously promoting the growth of axons26, and the transcription factors Cux127 and Sp428 were also found to have a negative regulatory effect on dendritic morphogenesis. Thus, identifying transcriptional repressors and signaling pathways that control dendrite morphogenesis and connectivity is of great importance for understanding the functions of the mature nervous system.
Maf1, a general transcriptional repressor and mTOR downstream effector, was found to be a negative regulator of Pol-dependent gene transcription29,30,31. Maf1 is well conserved in yeast, worms, fruit flies, plants, and mammals29. Previous studies have focused on its role in growth, metabolism, aging, cancer, and so on32. Recently, Maf1 was found to be highly expressed in the brain, enriched in the hippocampus and cortex, and highly expressed in the somatic and dendritic cytoplasm6. However, the role of Maf1 remains poorly characterized in the nervous system, such as in dendrites.
In this study, using ShRNAs to knock down Maf1 revealed that Maf1 knockdown promotes the branching of dendrites and the growth of dendritic spines (Figs. 1, 7), while Maf1 overexpression suppresses dendrite branching and dendritic spine growth (Figs. 2, 7). Rapid extension and arborization of dendrites occurs during the growth of dendrites33, and thus, the ability of Maf1 knockdown to promote the branching of dendrites may result from either the increased formation of new branches or the decelerated retraction of existing branches. Therefore, we revealed a novel role of Maf1 in neurons in that Maf1 may negatively regulate dendrite and spine morphogenesis. However, the mechanism responsible for the effect of Maf1 on dendrite morphology remains to be elucidated.
Palian et al. found that Maf1 is a downstream effector of PTEN/PI3K signaling, which is important for suppressing hepatocarcinogenesis by coregulating lipid metabolism and oncogenesis34. Furthermore, expression of Maf1 in PTEN-deficient human glioblastoma cells inhibits anchorage-independent growth29. Another study found that Maf1 suppresses hepatocarcinogenesis by suppressing AKT-mTOR signaling through activation of PTEN transcription35, which indicated Maf1 could also act as a transcription activator excepted for its canonical role as a transcriptional repressor. More recently, Taxifolin was found to bind with liver-X-receptor (α and β) to attenuate 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis through the mTOR/Maf1/PTEN pathway36. Therefore, Maf1 is a main effector of PTEN/PI3K signaling. While the PI3K/Akt/mTOR pathway has been implicated in dendritic morphogenesis16,37, it is likely that Maf1 mediates its effects on dendrite formation mainly through mTOR. Indeed, we found that Maf1 knockdown increased AKT and mTOR phosphorylation and decreased PTEN expression, while Maf1 overexpression decreased AKT and mTOR phosphorylation and increased PTEN expression (Fig. 4). Given the known role of mTOR in promoting dendritic outgrowth, persistent mTOR activation and decreased PTEN expression due to Maf1 knockdown is a plausible mechanism for dendritic growth. However, Kumar et al.37 found that overexpression of constitutively active PI3K or Akt significantly increased the number of filopodia protrusions, accompanied by a significant decrease in the density of mushroom-shaped spines, while chronic inhibition of PI3K/Akt/mTOR signaling by drug treatment reduced both dendritic spines and dendritic filopodia at 15 DIV. In the current study, we found that Maf1 knockdown in neurons increased the density of spines and mushroom-shaped spines, while overexpression of Maf1 reduced both dendritic spines and mushroom-shaped spines at 21 DIV. The difference is believed to be due to the different time points of observation, since 15 DIV is a stage during which dynamic dendritic filopodia are gradually replaced by mushroom-shaped mature spines in neurons37.
Rapamycin, a specific inhibitor of mTOR that blocks the effects of PI3K and Akt on dendrite branching16,37, was used in this study to test whether Maf1 regulates the growth of dendritic cells through mTOR. We revealed that rapamycin abolished the phenotypic effects of Maf1 knockdown (Fig. 5). In addition, PTEN, a negative regulator of the AKT-mTOR pathway, was found in this study to be positively correlated with the Maf1 level (Fig. 4), which negatively regulates dendrite branching, as PTEN knockdown by siRNA increased the branching of dendrite16. We also found that knockdown of PTEN by ShRNA increased the branching of dendrite and partially rescued the phenotypic effects of overexpressing Maf1 in neurons (Fig. 6). These data suggest that Maf1 inhibits dendritic growth mainly by suppressing AKT-mTOR signaling through activation of PTEN.
It is known that mTOR controls cell growth partially through the phosphorylation of the downstream effector p70S6K38. Jaworski et al.16 showed that p70S6K is indeed crucial for proper dendritic arborization. In this study, we found that Maf1 negatively regulates the expression of P70S6K (Fig. 4), suggesting that Maf1 may regulate translation through the mTOR pathway in the growth of dendrites. S6, the downstream target of p70S6Ks, which is largely controlled by PI3K/Akt/mTOR signaling37, was also found in this study to be negatively regulated by Maf1, which further indicated that Maf1 negatively regulates AKT-mTOR signaling in the dendritic growth of hippocampal neurons.
Dendrite branching patterns strongly influence the processing of information across the brain, and defects in dendrite architecture are associated with many neurodegenerative diseases39. Thus, a better understanding of the precise regulation of dendritic growth could provide useful insight for these pathological conditions. In this study, we assessed the role of Maf1 in proper hippocampal dendrite growth. In accordance with the stunted dendritic arbors of hippocampal cells observed following knockdown or overexpression of Maf1 in vivo, we found that these animals, especially rAAV-Maf1-OE mice, present behavioral deficits that involve hippocampal circuitry. However, rAAV-ShMaf1 mice only showed a significantly reduced latency from day 4 in the acquisition trials compared with scramble control rAAV-ShSCR mice, while there was no significant difference in the time spent in the quadrants between rAAV-ShMaf1 and rAAV-ShSCR mice, which may be attributed to compensatory effects. As changes in spines and synaptic connections are considered essential for learning and memory formation40,41, we speculate that the effects of Maf1 expression on learning and memory in mice may be due to Maf1 influencing the density of dendritic spines and the number of mushroom dendritic spines.
In conclusion, to the best of our knowledge, this is the first study to elucidate the role of Maf1 in dendritic morphogenesis and the growth of dendritic spines. We demonstrated that Maf1 inhibited dendritic morphogenesis and the growth of dendritic spines during neuron development. The function of Maf1 is exerted through AKT-mTOR signaling by regulating PTEN expression in dendrites.
References
McAllister, A. K. Cellular and molecular mechanisms of dendrite growth. Cereb. Cortex10, 963–973 (2000).
Ledda, F. & Paratcha, G. Mechanisms regulating dendritic arbor patterning. Cell. Mol. Life Sci.74, 4511–4537 (2017).
de la Torre-Ubieta, L. & Bonni, A. Transcriptional regulation of neuronal polarity and morphogenesis in the mammalian brain. Neuron72, 22–40 (2011).
Boguta, M. & Graczyk, D. RNA polymerase III under control: repression and de-repression. Trends Biochem. Sci.36, 451–456 (2011).
Upadhya, R., Lee, J. & Willis, I. M. Maf1 is an essential mediator of diverse signals that repress RNA polymerase III transcription. Mol. Cell10, 1489–1494 (2002).
Smith, K. R. et al. Identification and characterisation of a Maf1/Macoco protein complex that interacts with GABAA receptors in neurons. Mol. Cell. Neurosci.44, 330–341 (2010).
Michels, A. A. et al. mTORC1 directly phosphorylates and regulates human MAF1. Mol. Cell. Biol.30, 3749–3757 (2010).
Colombo, F., Racchetti, G. & Meldolesi, J. Neurite outgrowth induced by NGF or L1CAM via activation of the TrkA receptor is sustained also by the exocytosis of enlargeosomes. Proc. Natl Acad. Sci. USA111, 16943–16948 (2014).
Zhang, H. Y. et al. Regulation of autophagy and ubiquitinated protein accumulation by bFGF promotes functional recovery and neural protection in a rat model of spinal cord injury. Mol. Neurobiol.48, 452–464 (2013).
Lee, J. E. et al. S6K promotes dopaminergic neuronal differentiation through PI3K/Akt/mTOR-dependent signaling pathways in human neural stem cells. Mol. Neurobiol.53, 3771–3782 (2016).
Raab-Graham, K. F., Haddick, P. C., Jan, Y. N. & Jan, L. Y. Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites. Science314, 144–148 (2006).
Jossin, Y. & Goffinet, A. M. Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth. Mol. Cell. Biol.27, 7113–7124 (2007).
Urbanska, M., Gozdz, A., Swiech, L. J. & Jaworski, J. Mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) control the dendritic arbor morphology of hippocampal neurons. J. Biol. Chem.287, 30240–30256 (2012).
Luikart, B. W. et al. Pten knockdown in vivo increases excitatory drive onto dentate granule cells. J. Neurosci.31, 4345–4354 (2011).
Xu, N. J. & Henkemeyer, M. Ephrin-B3 reverse signaling through Grb4 and cytoskeletal regulators mediates axon pruning. Nat. Neurosci.12, 268–276 (2009).
Jaworski, J. et al. Control of dendritic arborization by the phosphoinositide-3’-kinase-Akt-mammalian target of rapamycin pathway. J. Neurosci.25, 11300–11312 (2005).
Zhu, X. N. et al. Ephrin-B3 coordinates timed axon targeting and amygdala spinogenesis for innate fear behaviour. Nat. Commun.7, 11096 (2016).
Chen, K., Gu, H., Zhu, L. & Feng, D. F. A new model of repetitive traumatic brain injury in mice. Front. Neurosci.13, 1417 (2019).
Hur, E. M., Saijilafu & Zhou, F. Q. Growing the growth cone: remodeling the cytoskeleton to promote axon regeneration. Trends Neurosci.35, 164–174 (2012).
Chen, R. Z., Akbarian, S., Tudor, M. & Jaenisch, R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet.27, 327–331 (2001).
Van Esch, H. et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet.77, 442–453 (2005).
Zhou, Z. et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron52, 255–269 (2006).
Cheng, T. L. et al. MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex. Dev. Cell28, 547–560 (2014).
Koch, J. C. et al. Plasmids containing NRSE/RE1 sites enhance neurite outgrowth of retinal ganglion cells via sequestration of REST independent of NRSE dsRNA expression. FEBS J.278, 3472–3483 (2011).
Giusti, S. A. et al. MicroRNA-9 controls dendritic development by targeting REST. Elife3, e02755 (2014).
de Anda, F. C. et al. Centrosome motility is essential for initial axon formation in the neocortex. J. Neurosci.30, 10391–10406 (2010).
Li, N., Zhao, C. T., Wang, Y. & Yuan, X. B. The transcription factor Cux1 regulates dendritic morphology of cortical pyramidal neurons. PLoS ONE5, e10596 (2010).
Ramos, B., Gaudilliere, B., Bonni, A. & Gill, G. Transcription factor Sp4 regulates dendritic patterning during cerebellar maturation. Proc. Natl Acad. Sci. USA104, 9882–9887 (2007).
Johnson, S. S. et al. Mammalian Maf1 is a negative regulator of transcription by all three nuclear RNA polymerases. Mol. Cell26, 367–379 (2007).
Lee, Y. L. et al. MAF1 represses CDKN1A through a Pol III-dependent mechanism. Elife4, e06283 (2015).
Willis, I. M. et al. Genetic interactions of MAF1 identify a role for Med20 in transcriptional repression of ribosomal protein genes. PLoS Genet.4, e1000112 (2008).
Zhang, S. S., Li, X. X., Wang, H. Y. & Zheng, X. F. S. Beyond regulation of pol III: role of MAF1 in growth, metabolism, aging and cancer. Biochim. Biophys. Acta Gene Regul. Mech.1861, 338–343 (2018).
Williams, D. W. & Truman, J. W. Mechanisms of dendritic elaboration of sensory neurons in Drosophila: insights from in vivo time lapse. J. Neurosci.24, 1541–1550 (2004).
Palian, B. M. et al. Maf1 is a novel target of PTEN and PI3K signaling that negatively regulates oncogenesis and lipid metabolism. PLoS Genet.10, e1004789 (2014).
Li, Y. et al. MAF1 suppresses AKT-mTOR signaling and liver cancer through activation of PTEN transcription. Hepatology63, 1928–1942 (2016).
Haque, M. W. et al. Taxifolin binds with LXR (alpha & beta) to attenuate DMBA-induced mammary carcinogenesis through mTOR/Maf-1/PTEN pathway. Biomed. Pharmacother.105, 27–36 (2018).
Kumar, V. et al. Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J. Neurosci.25, 11288–11299 (2005).
Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell169, 361–371 (2017).
Berry, K. P. & Nedivi, E. Spine dynamics: are they all the same? Neuron96, 43–55 (2017).
Lichtman, J. W. & Colman, H. Synapse elimination and indelible memory. Neuron25, 269–278 (2000).
Yang, G., Pan, F. & Gan, W. B. Stably maintained dendritic spines are associated with lifelong memories. Nature462, 920–924 (2009).
Acknowledgements
We thank Prof. Nan-Jie Xu and Prof. Su-Ya Sun for valuable discussion and Dr. Xian-Dong Liu for technique support. This research was supported by grants from the National Natural Science Foundation of China (81772059).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by D. Bano
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chen, K., Zhu, L., Guo, L. et al. Maf1 regulates dendritic morphogenesis and influences learning and memory. Cell Death Dis 11, 606 (2020). https://doi.org/10.1038/s41419-020-02809-y
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-020-02809-y
This article is cited by
-
Knockdown of Porf-2 restores visual function after optic nerve crush injury
Cell Death & Disease (2023)
-
BOD1 regulates the cerebellar IV/V lobe-fastigial nucleus circuit associated with motor coordination
Signal Transduction and Targeted Therapy (2022)
-
A novel mechanism for C1GALT1 in the regulation of gastric cancer progression
Cell & Bioscience (2021)